Navigation Links
A Magnetic Presence: Siemens New MRI Systems Pulling More Patients Toward the Benefits of MR Imaging
Date:11/20/2007

//www.winanmri.com. The program invites healthcare facilities with 180 beds or less that currently do not have a fixed MRI system to display their creativity and dedication to patient care by stating a two-minute case in short videos that prove why they should receive a free, new Essenza MRI from Siemens. Individuals from across the country can view the videos on the Web site and choose which facility they believe is most deserving of the MRI system. The facility whose video receives the most votes will be awarded a brand new MAGNETOM Essenza. Voting for this contest will close on Dec. 31, with the winner being announced in mid January.

MAGNETOM Verio and the Industry's Most Exciting Equation 3T + 70 cm + Tim

Siemens also introduced the MAGNEOTM Verio, the world's first 3T MRI with a 70-cm open bore. Siemens is still the only company to offer open bore technology at 1.5T and now introduces that imaging strength at 3T. This configuration leads to improved patient comfort, better workflow and reduced costs in high-end MR imaging for the diagnosis of challenging diseases.

The Verio represents a complete new class of MRI technology that delivers high-field diagnostic imaging to patients who typically have not had access to MR imaging. Due to the system's 70-cm bore diameter, the average distance between a patient's eyes and the magnet is 30 cm, greatly alleviating concerns of claustrophobia in many patients. In addition, the wider space makes it possible to scan patients who could not be examined with the MRI system in the past, including those suffering from kyphosis (limited mobility) or those who are in pain, as well as pediatric and obese patients up to 550 pounds, those who are dependent on medical devices, those who are in intensive care, and those having to undergo intraoperative procedures.

With a system length of only 173 cm, the MAGNETOM Verio is currently the shortest 3T MRI system on the market worldwide, while having the footprin
'/>"/>

SOURCE Siemens Medical Solutions
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Stereotaxis Highlights New Data on Acute Success in AFib Treatments With Niobe Magnetic Navigation System
2. Stereotaxis Showcases Interventional Cardiology Capabilities of Niobe Magnetic Navigation System
3. Stereotaxis Highlights Live Coronary and Peripheral Vascular Cases Performed at TCT With Stereotaxis Magnetic Navigation System
4. Siemens Announces Early Termination of Hart-Scott-Rodino Waiting Period For Acquisition of Dade Behring Holdings, Inc.; U.S. Antitrust Clearance Achieved
5. Siemens Extends Tender Offer for Acquisition of Dade Behring
6. Siemens Congratulates Kenneth R. Bertka, M.D., Recipient of 2007 AMDIS Award
7. MEDRAD Announces eCoil(TM) for Siemens, Philips 3.0T MR Scanners
8. VIDEO from Medialink and Siemens: The Next Generation Allergy Test - Nothing to Sneeze At
9. Siemens Building Technologies Pioneers Wireless Solution for St. Anthonys Sensitive Environment
10. Susquehanna Health and Siemens Announce Plans to Improve Hospital Facilities Through Technology Investment
11. Siemens Medical Solutions Diagnostics Announces the Release of the Rapidlab 1200 Series Version 2.0 Software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...swire-USNewswire/ -- The University of Texas M. ...a collaborative effort to eradicate breast cancer ...r Awareness and Research of the Americas today at ...ited States, and Vivian Fernandez de Torrijos, the...derson in the initiative are the U.S. Department o...
(Date:11/21/2008)...wswire/ -- The general membership of the Medical,... individuals at their Annual,Awards Dinner to be ...York. A,Lifetime Achievement Award will also be g... Advertising Hall of Fame are: , Ronald Pantell...t position,at Sudler & Hennessey. In 1980 he ...
(Date:11/21/2008)...d deadly diseaseits cause remains a mysteryswept i...g with citizens, soldiers and refugees of the war ...filled with corpses, social order broke down. Over...and Athens lost a third of its population. It lost...nning of the end of the Golden Age of Greece. , ...
(Date:11/21/2008)...wire/ -- Innerscope Research(TM), a revolutionary,...tional Response Measurement,announced today the ...n the,company,s research and development, busines...e three appointments, who deliver a combined 60 ye... Financial Officer and Vice President of,Strategy...
Breaking Medicine News(10 mins):Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 3Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 2Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 3Health News:Study of ancient and modern plagues finds common features 2Health News:Study of ancient and modern plagues finds common features 3Health News:Study of ancient and modern plagues finds common features 4Health News:Innerscope Research Strengthens Management Team With Three Executive Appointments 2
... feeling something is wrong with you and yet havin...k, 42 felt the same for almost the last 10 years b... multiple sclerosis (MS). MS is an disabling neur...by symptoms such as fatigue and limb weakness amon...
?????????????????????????????-Richard Bach For more than a week now, Noida, in Northern India, has been in the eye of the storm//. The events that unfolded revealed that two ‘local blisters’, Moninder
...est to detect infection of drug resistant forms of...n developed by Researchers at the Duke University ...ct drug-resistant viral strains even when present ...sts that detect drug-resistant strains only when p...
...ber of adults suffering severe heart problems due ...000 a study showed, //indicating the benefits of e...ssisted in better diagnosis and treatment, thus ex.... Congenital heart defects are capable of impedin...
Other Medicine News:Health News:In Search of Truth - 'Lie Detector 2Health News:In Search of Truth - 'Lie Detector 3Health News:In Search of Truth - 'Lie Detector 4
(Date:11/21/2008)...karia Holdings, Inc. today announced that it has b...ersey Technology Council (NJTC), a 1,200-member no...rt, networking opportunities, information and advo...karia earned the award based on criteria including...ision. , , "We are delighted that the New J...
(Date:11/20/2008)...T PHASE III TRIAL SHOW SIGNIFICANT, DECREASES...CTION, IN, FIBROMYALGI... Belgium, Nov. 20 /PRNewswire-FirstCall/,-- Jazz ...uronext Brussels: UCB),announced today positive p...,Phase III pivotal clinical trials of sodium oxyba...
(Date:11/20/2008)...- Radius Health ("Radius") announced today that it...d institutional financing round, increasing total ... amount raised since the company,s inception to $1... participated in the financing, led by MPM Bio IV ...Wellcome Trust, HealthCare Ventures, Oxford Biosci...
(Date:11/19/2008)...re-FirstCall/ -- Amgen,(Nasdaq: AMGN ) and Mill...of,Takeda Pharmaceutical Company Limited (TSE: 40... 3 MONET1 trial evaluating motesanib (AMG 706) in,...he first-line treatment of,advanced non-small cel...ed,following a planned safety data review of 600 ...
Breaking Medicine Technology:Ikaria(R) Named Private Company of the Year by New Jersey Technology Council 2Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 2Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 3Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 4Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 5Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 6Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7Schering Plough Schedules Conference Call and Webcast for 2007 Third Quarter Earnings 1754 1AUDIO from Medialink and Kelloggs 3A The Jeans Dont Lie 1752 12007 Speakers Golf Tournament Sets 5 Year Fundraising Record 1750 12007 Speakers Golf Tournament Sets 5 Year Fundraising Record 1750 2APHA Urges President Bush to Reconsider Unfounded Basis for SCHIP Veto 1748 1APHA Urges President Bush to Reconsider Unfounded Basis for SCHIP Veto 1748 2
LH EIA Reproductive Markers 025-BC-1031 Luteinizing Hormone
...procedure follows the basic principle of a competi... between an unlabeled antigen and an labelled anti...ic antiserum . The amount of enzyme conjugate comp... the antibody is inversely proportional to the con...
...droepiandrosterone (5-Androstene-3-0L-17-one,Andro...ndrosterone, DHEA) is a steroid hormone present in...DHEA-S ELISA kit is based on the competition princ...mount of DHEA-S present in the sample and a fixed ...
...otensin Converting Enzyme (ACE), also known as Kin....15.1) with a molecular weight of at least 129,000...e polypeptide chain, a polysaccharide residue and ... types such as neuronal cells and renal proximal t...
Medicine Products: